The Valley Desk

Clinical trial reportCancerPublished

Efficacy and safety of teclistamab in triple-class exposed relapsed/refractory multiple myeloma: Pooled findings from three clinical cohorts and a retrospective cohort

Read the publication ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Perelman School of Medicine, University of Pennsylvania. Affiliation source

Publication record

Type
Clinical trial report
Venue
Cancer
Published
Subject terms
Humans; Multiple Myeloma; Neoplasm Recurrence, Local; Antibodies, Bispecific; Treatment Outcome; Retrospective Studies; Cohort Studies; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
41485109
Added to directory
Source checked

Report a correction or request removal